--- title: "Xintian Pharma: Subsidiary Zhongdao Health registered capital of 10 million yuan" type: "News" locale: "en" url: "https://longbridge.com/en/news/255755656.md" description: "Xintian Pharma announced that its wholly-owned subsidiary, Guizhou Zhongdao Traditional Chinese Medicine Health Technology Co., Ltd., has a registered capital of 10 million yuan, with Wei Maochen as the legal representative, established on September 1, 2025. The business scope includes the production and sales of health food and related products. This investment aims to promote the research and development of health food, improve the product matrix, enhance profitability and risk resistance, and assist the company in achieving its strategic goal of becoming a comprehensive pharmaceutical enterprise" datetime: "2025-09-03T09:48:20.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/255755656.md) - [en](https://longbridge.com/en/news/255755656.md) - [zh-HK](https://longbridge.com/zh-HK/news/255755656.md) --- # Xintian Pharma: Subsidiary Zhongdao Health registered capital of 10 million yuan Xintian Pharma announced that the company has invested RMB 10 million of its own funds to establish a wholly-owned subsidiary, Guizhou Zhongdao Traditional Chinese Medicine Health Technology Co., Ltd., and has received the business license issued by the Market Supervision Administration of Wudang District, Guiyang City. Zhongdao Health has a registered capital of RMB 10 million, with Wei Maochen as the legal representative, and was established on September 1, 2025. The business scope includes the production of health food, food production, production of special medical purpose formula food, production of infant formula food, production of food additives, production of dairy products, production of beverages, and food sales. This investment aims to promote the research and development of health food and the transformation of results, improve the company's diversified product matrix, enhance the overall profitability and risk resistance capability of the company, and accelerate the achievement of the strategic goals of a comprehensive pharmaceutical enterprise ### Related Stocks - [002873.CN](https://longbridge.com/en/quote/002873.CN.md) ## Related News & Research - [16:51 ETBeverly Hills MD ProRetinol Age Rewind x3 Officially Launches: A New Era of Gentle, Slow-Released Retinol Skincare Backed by Plastic Surgeons](https://longbridge.com/en/news/286966075.md) - [Orkla’s OV UK Buys Phoenix Brands to Boost Sweet Ingredients Footprint](https://longbridge.com/en/news/286763926.md) - [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md) - [](https://longbridge.com/en/news/286948461.md) - [BCAL Diagnostics Expands National Access to Early Cancer Detection Blood Tests](https://longbridge.com/en/news/286850851.md)